Cargando…
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
The inflammatory bowel diseases (IBDs) are lifelong chronic illnesses that place an immense burden on patients. The primary aim of therapy is to reduce disease burden and prevent relapse. However, the occurrence of relapses is often unpredictable. Current disease monitoring is primarily by way of cl...
Autores principales: | Galgut, Bianca J., Lemberg, Daniel A., Day, Andrew S., Leach, Steven T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780398/ https://www.ncbi.nlm.nih.gov/pubmed/29404311 http://dx.doi.org/10.3389/fped.2017.00292 |
Ejemplares similares
-
Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017) -
Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021) -
The Pathophysiology of Eosinophilic Esophagitis
por: Raheem, Mayumi, et al.
Publicado: (2014) -
Fecal Biomarkers of Intestinal Health and Disease in Children
por: Pang, Tamara, et al.
Publicado: (2014) -
Inflammatory Bowel Disease in Children of Middle Eastern Descent
por: Naidoo, Christina Mai Ying, et al.
Publicado: (2014)